Financial Architects (New Jersey)’s Dr. Reddy's Laboratories RDY Stock Holding History

Financial Architects (New Jersey)’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-500	Closed	-$4K	–	1606
2017 Q1	$4K	Hold	500	–	–	﹤0.01%	1340
2016 Q4	$5K	Hold	500	–	–	﹤0.01%	1160
2016 Q3	$5K	Hold	500	–	–	﹤0.01%	1154
2016 Q2	$5K	Hold	500	–	–	﹤0.01%	1130
2016 Q1	$5K	Buy	+500	New	+$4.47K	﹤0.01%	902
2015 Q3	–	Sell	-500	Closed	-$6K	–	748
2015 Q2	$6K	Hold	500	–	–	﹤0.01%	916
2015 Q1	$6K	Hold	500	–	–	﹤0.01%	845
2014 Q4	$5K	Hold	500	–	–	﹤0.01%	837
2014 Q3	$5K	Buy	+500	New	+$4.7K	﹤0.01%	749

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Financial Architects (New Jersey)'s RDY Position: Q2 2017 in Review

Financial Architects (New Jersey) sold out of Dr. Reddy's Laboratories (RDY) in Q2 2017, closing a stake of 500 shares — an estimated $4K sold.

Financial Architects (New Jersey) first reported a position in RDY in Q3 2014 and held it in 9 quarters. The position peaked at $6K in Q2 2015. 128 funds tracked by Wall St. Rank hold RDY as of Q2 2017.

Financial Architects (New Jersey) reported no remaining Dr. Reddy's Laboratories position as of Q2 2017 after selling out during the quarter.
Financial Architects (New Jersey) sold 500 Dr. Reddy's Laboratories shares in Q2 2017, an estimated $4K.
Financial Architects (New Jersey) first reported a position in Dr. Reddy's Laboratories in Q3 2014 and held it in 9 quarters.
Financial Architects (New Jersey)'s Dr. Reddy's Laboratories position peaked at $6K in Q2 2015.
128 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2017.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2017, filed 21 Jul 2017.